Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Cash from Operations (2018 - 2026)

Viemed Healthcare filings provide 8 years of Cash from Operations readings, the most recent being 18441000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 23.05% to 18441000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 51916000.0, a 32.81% increase, with the full-year FY2025 number at 51916000.0, up 32.81% from a year prior.
  • Cash from Operations hit 18441000.0 in Q4 2025 for Viemed Healthcare, roughly flat from 18367000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 18441000.0 in Q4 2025 to a low of 1175000.0 in Q1 2024.
  • Median Cash from Operations over the past 5 years was 8313500.0 (2021), compared with a mean of 9322950.0.
  • Biggest five-year swings in Cash from Operations: surged 662.44% in 2021 and later plummeted 88.81% in 2024.
  • Viemed Healthcare's Cash from Operations stood at 8655000.0 in 2021, then decreased by 11.22% to 7684000.0 in 2022, then surged by 72.88% to 13284000.0 in 2023, then increased by 12.82% to 14987000.0 in 2024, then rose by 23.05% to 18441000.0 in 2025.
  • The last three reported values for Cash from Operations were 18441000.0 (Q4 2025), 18367000.0 (Q3 2025), and 12254000.0 (Q2 2025) per Business Quant data.